Chesnara (LON:CSN) Price Target Raised to GBX 404

Chesnara (LON:CSN) had its price objective raised by Berenberg Bank from GBX 373 to GBX 404 in a research report report published on Friday morning, Marketbeat.com reports. The firm currently has a buy rating on the stock.

Separately, Royal Bank Of Canada lowered their price objective on shares of Chesnara from GBX 370 to GBX 360 and set an “outperform” rating for the company in a research note on Wednesday, April 15th. Two research analysts have rated the stock with a Buy rating, According to data from MarketBeat.com, the company presently has an average rating of “Buy” and a consensus target price of GBX 382.

Chesnara Price Performance

CSN opened at GBX 340.50 on Friday. The company has a market capitalization of £785.42 million, a price-to-earnings ratio of -67.43 and a beta of 0.52. The company has a current ratio of 2.92, a quick ratio of 38.06 and a debt-to-equity ratio of 49.41. Chesnara has a 12-month low of GBX 258 and a 12-month high of GBX 344.47. The business’s fifty day simple moving average is GBX 328.89 and its 200-day simple moving average is GBX 314.40.

Insider Buying and Selling

In related news, insider Tom Howard sold 55,544 shares of the business’s stock in a transaction that occurred on Monday, May 18th. The shares were sold at an average price of GBX 319, for a total value of £177,185.36. 0.82% of the stock is owned by company insiders.

Chesnara Company Profile

Chesnara (CSN.L) is a European life and pensions consolidator listed on the London Stock Exchange. It administers approximately one million policies and operates as Countrywide Assured in the UK, as The Waard Group and Scildon in the Netherlands, and as Movestic in Sweden.

Following a three-pillar strategy, Chesnara’s primary responsibility is the efficient administration of its customers’ life and savings policies, ensuring good customer outcomes and providing a secure and compliant environment to protect policyholder interests.